These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8345001)

  • 21. Liquid chromatographic determination of fusidic acid in serum.
    Sørensen H
    J Chromatogr; 1988 Sep; 430(2):400-5. PubMed ID: 3235513
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg).
    Vaillant L; Machet L; Taburet AM; Sorensen H; Lorette G
    Br J Dermatol; 1992 Jun; 126(6):591-5. PubMed ID: 1610710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic investigation of fusidic acid 1% viscous eye drops in healthy volunteers.
    Thorn P; Johansen S
    Eur J Ophthalmol; 1997; 7(1):9-12. PubMed ID: 9101188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
    Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
    Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension.
    Johansen S; Rask-Pedersen E; Prause JU
    Acta Ophthalmol Scand; 1996 Jun; 74(3):253-8. PubMed ID: 8828722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
    Still JG; Clark K; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S504-12. PubMed ID: 21546627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ceftibuten in children.
    Barr WH; Affrime M; Lin CC; Batra V
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S93-101. PubMed ID: 7567317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.
    Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT
    Eur J Clin Pharmacol; 2001; 56(11):805-11. PubMed ID: 11294370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of fusidic acid.
    Reeves DS
    J Antimicrob Chemother; 1987 Oct; 20(4):467-76. PubMed ID: 3316149
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and bioequivalence of different formulations of pirenzepine.
    Vergin H; Mascher H; Strobel K; Nitsche V
    Arzneimittelforschung; 1986 Sep; 36(9):1409-12. PubMed ID: 3790194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of prednisolone in rabbits: comparison of a high-viscosity gel and an aqueous suspension--single- and repeated applications.
    Johansen S; Rask-Pedersen E; Prause JU
    Adv Exp Med Biol; 1994; 350():399-402. PubMed ID: 8030508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.